In fact, both peptide-primed and lysate-primed T-cells proved capable of cross-recognizing whole cell MUC1-expressing tumor digests at a higher frequency than non-MUC1 expressing digests (Fig 3E). This evidence concerns the gene MUC1 and neoplasm.